Center of Drug Discovery, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, PR China.
Peptides. 2011 Dec;32(12):2497-503. doi: 10.1016/j.peptides.2011.10.005. Epub 2011 Oct 8.
Cathelicidin-BF15 (BF-15) is a 15-mer peptide derived from Cathelicidin-BF (BF-30), which is found in the venom of the snake Bungarus fasciatus and exhibits broad antimicrobial activity. Since BF-15 retains most part of the antimicrobial activity of BF-30 but has significantly reduced haemolytic activity and a much shorter sequence length (and less cost), it is a particularly attractive template around which to design novel antimicrobial peptides. However, the structure-activity relationship of it is still unknown. We designed and synthesized a series of C-terminal amidated analogs of BF-15 based on its amphipathic α-helix structure. And we characterized their antimicrobial potency and haemolytic activity. We identified the amidated BF-15 (analog B1) with potent antimicrobial activity against several antibiotic-resistant bacteria (MICs between 1 and 64 μg/mL, 2-16-folds higher than BF-30) and much lower haemolytic activity. The subsequent circular dichroism study results showed a typical α-helix pattern of analog B1 and the content of the α-helix structure of it increased significantly comparing with BF-30, which indicates the peptide sequence of BF-15 may provide a major contribution to the α-helix content of the whole BF-30 sequence. The peptide induced chaotic membrane morphology and cell debris as determined by electron microscopy. This suggests that the antimicrobial activity of B1 is based on cytoplasmic membrane permeability. Taken together, our results suggested that peptide B1 should be considered as an excellent candidate for developing therapeutic drugs.
Cathelicidin-BF15 (BF-15) 是一种 15 肽,来源于蛇 Bungarus fasciatus 毒液中的 Cathelicidin-BF (BF-30),具有广谱抗菌活性。由于 BF-15 保留了 BF-30 的大部分抗菌活性,但溶血活性显著降低,序列长度更短(成本更低),因此它是设计新型抗菌肽的理想模板。然而,其结构-活性关系尚不清楚。我们根据 BF-15 的两亲性α-螺旋结构设计并合成了一系列 C 端酰胺化的 BF-15 类似物,并对其抗菌活性和溶血活性进行了表征。我们发现酰胺化 BF-15(类似物 B1)对几种抗生素耐药菌具有很强的抗菌活性(MIC 在 1 到 64 μg/mL 之间,比 BF-30 高 2-16 倍),溶血活性显著降低。随后的圆二色性研究结果表明,类似物 B1 呈现典型的α-螺旋结构,与 BF-30 相比,其α-螺旋结构含量显著增加,这表明 BF-15 的肽序列可能对 BF-30 整个序列的α-螺旋结构含量有较大贡献。电镜观察结果显示,该肽可诱导混乱的膜形态和细胞碎片。这表明 B1 的抗菌活性基于细胞质膜通透性。综上所述,我们的研究结果表明,肽 B1 可作为开发治疗药物的候选物。